Literature DB >> 26561480

INFLUENZA SURVEILLANCE IN RUSSIA BASED ON EPIDEMIOLOGICAL AND LABORATORY DATA FOR THE PERIOD FROM 2005 TO 2012.

Sominina Anna1, Elena Burtseva2, Mikhail Eropkin1, Ludmila Karpova1, Vladimir Zarubaev1, Elizaveta Smorodintseva1, Nadezhda Konovalova1, Daria Danilenko1, Alexandra Prokopetz1, Mikhail Grudinin1, Maria Pisareva1, Pavel Anfimov1, Kirill Stolyarov1, Oleg Kiselev1, Elena Shevchenko2, Valeriya Ivanova2, Svetlana Trushakova2, Nataliya Breslav2, Dmitriy Lvov2, Alexander Klimov3, Ann Moen3, Nancy Cox3.   

Abstract

Exchange of information on and sharing of influenza viruses through the GISRS network has great significance for understanding influenza virus evolution, recognition of a new pandemic virus emergence and for preparing annual WHO recommendations on influenza vaccine strain composition. Influenza surveillance in Russia is based on collaboration of two NICs with 59 Regional Bases. Most epidemiological and laboratory data are entered through the internet into the electronic database at the Research Institute of Influenza (RII), where they are analyzed and then reported to the Ministry of Public Health of Russia. Simultaneously, data are introduced into WHO's Flu Net and Euro Flu, both electronic databases. Annual influenza epidemics of moderate intensity were registered during four pre-pandemic seasons. Children aged 0-2 and 3-6 years were the most affected groups of the population. Influenza registered clinically among hospitalized patients with respiratory infections for the whole epidemic period varied between 1.3 and 5.4% and up but to 18.5-23.0% during the peak of the two pandemic waves caused by influenza A(H1N1) pdm 09 virus and to lesser extent (2.9 to 8.5%) during usual seasonal epidemics. Most epidemics were associated with influenza A(H1N1), A(H3N2) and B co-circulation. During the two pandemic waves (in 2009-2010 and 2010-2011) influenza A(H1N1) pdm 09 predominated. It was accompanied by a rapid growth of influenza morbidity with a significant increase of both hospitalization and mortality. The new pandemic virus displaced the previous seasonal A(H1N1) virus completely. As a rule, most of the influenza viruses circulating in Russia were antigenic ally related to the strains recommended by WHO for vaccine composition for the Northern hemisphere with the exception of two seasons when an unexpected replacement of the influenza B Victoria lineage by Yamagata lineage (2007-2008) and the following return of Victoria lineage viruses (2008-2009) was registered. Influenza surveillance in Russia was improved as a result of enhancing capacity to international standards and the introduction of new methods in NICs such as rRT-PCR diagnosis, regular testing of influenza viruses for susceptibility to antivirals, phylogenetic analysis as well as organization of sentinel surveillance in a number of Regional Base Laboratories. Improvements promoted rapid recognition of the appearance a new pandemic virus in the country and enhancement of confirmation tests in investigation of influenza related death cases.

Entities:  

Keywords:  Antigenic Properties; Antivirals; Hospitalization; Influenza; Laboratory Confirmation; Morbidity; Mortality; Sentinel Surveillance; Virus; Virus Isolation

Year:  2013        PMID: 26561480      PMCID: PMC4639464          DOI: 10.3844/ajidsp.2013.77.93

Source DB:  PubMed          Journal:  Am J Infect Dis        ISSN: 1553-6203


  11 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  The genomic rate of molecular adaptation of the human influenza A virus.

Authors:  Samir Bhatt; Edward C Holmes; Oliver G Pybus
Journal:  Mol Biol Evol       Date:  2011-03-16       Impact factor: 16.240

3.  [The 24 May, 2009 isolation of the first A/IIV-Moscow/01/2009 (H1N1)swl strain similar to swine A(H1N1) influenza virus from the first Moscow case detected on May 21, 2009, and its deposit in the state collection of viruses (SCV No. 2452 dated May 24, 2009)].

Authors:  D K L'vov; E I Burtseva; A G Prilipov; M V Bazarova; L V Kolobukhina; L N Merkulova; N A Malyshev; P G Deriabin; I T Fediakina; G K Sadykova; E V Usachev; M Iu Shchelkanov; E S Shevchenko; S V Trushakova; V T Ivanova; N V Beliakova; T A Oskerko; T I Aliper
Journal:  Vopr Virusol       Date:  2009 Sep-Oct

4.  [Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center].

Authors:  A A Solomina; M P Grudinin; M Iu Eropkin; L S Karpova; M M Pisareva; A B Komissarov; N I Konovalova; T M Gudkova; D M Danilenko; E A Smorodintseva; E M Voĭtsekhovskaia; O I Kiselev
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  2011 May-Jun

5.  [Etiological characteristics of the influenza epidemics of 2006-2009 in the Russian Federation (according to the data of the Research Institute of Influenza, North-Western Branch, Russian Academy of Medical Sciences)].

Authors:  N I Konovalova; M Iu Eropkin; T M Gudkova; V A Grigor'eva; D M Danilenko; A V Ivanova; T S Smirnova; T G Lobova; S M Shchekanova
Journal:  Vopr Virusol       Date:  2010 Jul-Aug

6.  Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.

Authors:  Donald F Smee; Brett L Hurst; Min-Hui Wong; Kevin W Bailey; John D Morrey
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

7.  Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.

Authors:  Lizheng Guo; Rebecca J Garten; Angie S Foust; Wendy M Sessions; Margaret Okomo-Adhiambo; Larisa V Gubareva; Alexander I Klimov; Xiyan Xu
Journal:  Antiviral Res       Date:  2009-01-31       Impact factor: 5.970

8.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Authors:  Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

9.  Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.

Authors:  Natalie Pica; Rong Hai; Florian Krammer; Taia T Wang; Jad Maamary; Dirk Eggink; Gene S Tan; Jens C Krause; Thomas Moran; Cheryl R Stein; David Banach; Jens Wrammert; Robert B Belshe; Adolfo García-Sastre; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 10.  Reconstruction of the 1918 influenza virus: unexpected rewards from the past.

Authors:  Jeffery K Taubenberger; David Baltimore; Peter C Doherty; Howard Markel; David M Morens; Robert G Webster; Ian A Wilson
Journal:  MBio       Date:  2012-09-11       Impact factor: 7.867

View more
  4 in total

1.  Seasonal pattern of influenza activity in a subtropical city, China, 2010-2015.

Authors:  Xu-Xiang Liu; Yahong Li; Yibing Zhu; Juanjuan Zhang; Xiaoru Li; Junqing Zhang; Kefu Zhao; Mingxia Hu; Guoyou Qin; Xi-Ling Wang
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

2.  Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010-2015.

Authors:  Tommy T Lam; Julian W Tang; Florence Y Lai; Hassan Zaraket; Ghassan Dbaibo; Seweryn Bialasiewicz; Sarah Tozer; Jean-Michel Heraud; Steven J Drews; Todd Hachette; Paul Ks Chan; Evelyn Sc Koay; Hong Kai Lee; Kok Keng Tee; Yang Liu; Pieter LA Fraaij; Lance Jennings; Matti Waris; Mel Krajden; André Corriveau; Hamid Jalal; Hidekazu Nishimura; Pagbajabyn Nymadawa; Darmaa Badarch; Aripuana Watanabe; Alice Kabanda; Theo Sloots; Jen Kok; Dominic E Dwyer; Marion Koopmans
Journal:  J Infect       Date:  2019-07-16       Impact factor: 6.072

3.  Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.

Authors:  Natalie Fischer; Nicolas Dauby; Nathalie Bossuyt; Marijke Reynders; Michèle Gérard; Patrick Lacor; Siel Daelemans; Bénédicte Lissoir; Xavier Holemans; Koen Magerman; Door Jouck; Marc Bourgeois; Bénédicte Delaere; Sophie Quoilin; Steven Van Gucht; Isabelle Thomas; Cyril Barbezange; Lorenzo Subissi
Journal:  Lancet Microbe       Date:  2021-01-27

4.  A comparative analysis of the epidemiology of influenza and respiratory syncytial virus in Russia, 2013/14 to 2018/19.

Authors:  Saverio Caini; Kirill Stolyarov; Anna Sominina; Elizaveta Smorodintseva; Lisa Staadegaard; John Paget; Daria Danilenko
Journal:  J Glob Health       Date:  2022-02-05       Impact factor: 4.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.